We are proud to announce that Ya-Chieh Hsu, PhD, has been selected by the Pew Charitable Trust to receive an early-career award that will fund her research for the next four years. Hsu joined the Department of Stem Cell and Regenerative Biology at Harvard as an assistant professor in 2014, at which time she also became Principal Faculty at the Harvard Stem Cell Institute. Her research is focused on uncovering the function and potential of transit-amplifying skin cells, which play a key role in tissue development, regeneration, and are especially sensitive to chemotherapy drugs. Understanding the role these cells play in skin regeneration could lead to the development of therapies that alleviate or prevent some of the side effects of chemotherapy, such as hair loss and compromised wound healing.

We have asked Hsu to share her impressions upon receiving the award.

Read more about Ya-Chieh Hsu named 2017 Pew scholar

Adapted from a Boston Children's Hospital press release. 

Two golden retrievers that had the genetic mutation for Duchenne muscular dystrophy (DMD), yet remained healthy, have offered up yet another lead for treating this muscle-wasting disorder.

For several years, Natássia Vieira, PhD, of the University of São Paolo, also a fellow in the Boston Children’s Hospital lab of HSCI Principal Faculty  Read more about Two resilient dogs point to new targets for Duchenne muscular dystrophy

New technique raises possibility of making all types of blood cells to treat disease

By Nancy Fliesler, Boston Children's Hospital Communications

Harvard Stem Cell Institute researchers at Boston Children’s Hospital have, for the first time, generated blood-forming stem Read more about Approaching a decades-old goal: making blood stem cells from patients’ own cells